CURIS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
CURIS, INC. (CRIS) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.15 per share for the 3-month period ending 2012-12-31, per its 10-K filed 2014-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2014-03-13
- CURIS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2012-12-31 was -$0.15, a 314.29% decline year-over-year.
- CURIS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2012-09-30 was -$0.04.
- CURIS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2012-06-30 was -$0.04.
- CURIS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2012-03-31 was $0.03.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month |
|---|---|
| 2012-12-31 | -$0.15 10-K · filed 2014-03-13 |
| 2012-09-30 | -$0.04 10-K · filed 2014-03-13 |
| 2012-06-30 | -$0.04 10-K · filed 2014-03-13 |
| 2012-03-31 | $0.03 10-K · filed 2014-03-13 |
| 2011-12-31 | $0.07 10-K · filed 2013-03-13 |
| 2011-09-30 | -$0.05 10-K · filed 2013-03-13 |
| 2011-06-30 | -$0.06 10-K · filed 2013-03-13 |
| 2011-03-31 | -$0.09 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |